GENEPEUTIC BIO CO., LTD.
The First GMP-Certified Cell and Gene Therapy
Manufacturing Facility in Thailand.
Genepeutic Bio was founded in 2020 to deliver the next wave of personalized cell and gene therapy for patients in Asia, initiating with Chimeric antigen receptor (CAR) T-cells.
CDMO SERVICES
Genepeutic Bio is a contract development and manufacturing organization (CDMO) providing services for CAR T-cells production. Under a GMP-Certified facility, which meets the international standard, we ensure the quality of our products and services for patient’s safety.
CAR T-cell
Manufacturing
Facility
The First GMP-Certified for Cell and Gene Therapy in Thailand
The facility complies with the international standards utilizing the lastest technology of CAR-T to fight cancer but ensure patient’s safety through extensive list of quality release testings.
CELL AND GENE THERAPY
This technology, classified as advanced therapy medicinal products (ATMPs), utilizes the body’s own immune cells, T-cells, that undergoes gene modification to treat the deliberating diseases such as cancers.
THE PRODUCT
Anti-CD19 CAR T-cells (2nd Generation)
Indications: Relapsed/Refractory CD19 Positive B-cell Malignancies
LATEST NEWS
- June 12, 2024
- News & Events
MHESI Minister Visits Genepeutic Bio’s Cell and Gene Production Unit
On 29 May 2024, the Minister of Higher Education, Science, Research and Innovation (MHESI), Ms. Supamas Isarabhakdi, visited the Cell and Gene Production Unit (CPU) operated by the Thailand Center of Excellence for Life Sciences (TCELS) together with executives and researchers from Genepeutic Bio. The visit highlighted Thailand’s progress
- April 25, 2023
- News & Events
Mahidol University Announces Successful CAR T-Cell Treatment of 10 Patients
On 19 April 2023, Mahidol University announced the success of Thailand’s first CAR T-cell therapy program manufactured under international standards — the first of its kind in ASEAN. Ten patients, both children and adults, with blood cancers resistant to multiple chemotherapy regimens and targeted therapies were treated with CD19
- May 26, 2021
- News & Events
THEIR OWN MEDICINE : Our Story from The Economist
Biotech entrepreneurs are building on Thailand’s robust industry ecosystem to make advanced health care more accessible.
- April 5, 2021
- News & Events
Genepeutic Bio Gets Supports from Thailand Board of Investment
Thai Board of Investments approves business promotions for 4 new Biotech Project including Genepeutic Bio project for developing advanced cell therapy medicines.